Sanofi make generic of Pfizer's Lipitor -paper | Reuters: "(Reuters) - Sanofi has won a licence from Pfizer to make a generic of the U.S. drugmaker's cholesterol treatment Lipitor, the world's best-selling treatment, which will lose patent protection next year."
'via Blog this'
Consultoria especializada em GMP/BPF para indústrias voltadas a Ciências da Vida!
Nenhum comentário:
Postar um comentário